Influence of copper source and dietary inclusion level on growth performance of weaned pigs and expression of trace element related genes in the small intestine.

Copper is routinely supplemented to weanling pig diets at concentrations above nutritional requirements to enhance growth performance. We hypothesised that this effect depends on the source of Cu and its dietary concentration. We tested this in weaned pigs (26 d of age) over a 35-d period using a 2 × 3 factorial arrangement with two Cu-sources (CuSO4 and Cu2O, monovalent copper oxide, CoRouge®) and three supplementary dietary Cu-levels (15, 80 and 160 mg Cu/kg) as respective factors. Increasing Cu level linearly increased (P < 0.001) final BW and daily gain. These effects tended (P = 0.09) to be greater with Cu2O than CuSO4. Feed conversion ratio decreased linearly (P < 0.001) with increasing dietary Cu content, independent of Cu source. Plasma Cu, Zn and Fe levels were unaffected, whereas liver Cu content increased quadratically (P < 0.001) with increasing dietary Cu content, with a larger increase (P < 0.001) with CuSO4 than Cu2O. Bile Cu content increased quadratically (P = 0.025) with increasing Cu content, irrespective of Cu source. RT-qPCR analysis revealed that increasing Cu content quadratically (P = 0.009) increased duodenal but not ileal metallothionein 1A (MT1A) mRNA, with greater effect (P = 0.010) of CuSO4. Regardless of the Cu source, increasing Cu dose linearly increased (P = 0.006) duodenal DMT1/SLC11A2 mRNA but decreased ZIP4/SLC39A4 mRNA in duodenum (P < 0.001) and ileum (P < 0.005). ZnT10/SLC30A10 mRNA was significantly (P = 0.021) and numerically (P = 0.061) greater with Cu2O compared to CuSO4, in duodenum and ileum, respectively. Copper content quadratically modulated duodenal but not ileal transferrin receptor (P = 0.029) and ferric reductase CYBRD1 mRNA (P = 0.022). In hypothalamus, high Cu dose (P = 0.024) and Cu2O as source (P = 0.028) reduced corticotropin-releasing hormone (CRH) mRNA. Low versus high CuSO4 increased corticotropin-releasing hormone receptor (CRHR2) mRNA, while low Cu2O had the opposite effect (P = 0.009). In conclusion, incremental Cu intake enhanced growth performance, with a tendency for a greater effect of Cu2O. The lower increase in duodenal MT1A mRNA and liver Cu content indicates that less Cu from Cu2O was absorbed by gut and sequestered in liver. Thus, high Cu absorption is not essential for its growth-promoting effect and dietary Cu may affect intestinal Fe and Zn absorption via the active, transcellular route. The effects on hypothalamic CRH and CRHR2 expression indicate a role for the hypothalamus in mediating the effects of Cu on growth performance.

Effect of the physicochemical properties of zinc oxide sources on their bioavailability in broilers.

1. The bioavailability of a trace mineral source is related to its intestinal solubility (bioaccessibility), which in turn is determined by its physicochemical properties. It is still not clear which characteristics are more relevant in affecting solubility and bioavailability of mineral sources. Zinc oxide (ZnO) is a common feed additive used to supplement zinc in the diet of monogastric animals. However, different sources have shown variable responses on animal bioavailability.2. This study hypothesised that different sources of feed grade ZnO have various physicochemical features that lead to distinct bioavailability values. Feed grade ZnO samples collected from the feed industry worldwide were characterised for their physicochemical features and tested in broilers to allow bioavailability determined.3. A total of 135 male Cobb broiler chickens were fed a standard starter diet from day 1 after hatching up to d 7. At d 8, animals were allocated in individual cages and fed one of the following dietary treatments during 15 days: a basal diet with 23.5 ppm of zinc and seven test diets with supplemented ZnO or zinc sulphate (ZnSO4) at 6 or 12 ppm.4. Different sources of ZnO showed an effect of solubility in the stomach and supplementation influenced total Zn levels in the ileum. The bioavailability of the different sources varied from 49% to 160% in relation to ZnSO4. Aggregate size of particles seems to explain most of the variability in the bioavailability of the different sources tested in broilers. In conclusion, physicochemical properties of ZnO can partly explain the variability observed in terms of biological value.

Inhibitory action of two zinc oxide sources on the ex vivo growth of porcine small intestine bacteria.

Pharmacological dosage of zinc oxide in piglet weaning diets is a common practice to improve growth performance and gut health. However, high zinc excretion in animal wastes poses environmental challenges. Alternatives to current practice are studied. In this study, the inhibitory action of 2 zinc oxide sources on the ex vivo growth of small intestinal bacteria from weaned piglets was studied. Lag time was higher (P < 0.05) in media supplemented with a new zinc oxide preparation in stomach samples, but not in jejunum samples. Bacterial growth reduction (P < 0.05) was more drastic and more rapid in media supplemented with the new zinc oxide preparation.

Zinc oxide at low supplementation level improves productive performance and health status of piglets.

Use of ZnO at high doses (3000 ppm) for diarrhea prophylaxis in piglets is widely extended in postweaning Spanish diets, in compliance with the national veterinary regulation. However, European feed legislation limits total dietary Zn to a maximum of 150 mg/kg of complete feed. The objective of this study was to compare a new potentiated form of ZnO, HiZox (Animine), at nutritional level (150 ppm) with pharmacological dosage (3000 ppm) of regular ZnO in starter diets on the productive performance and health status of piglets in a medium-low health status farm. A total of 144 pigs at weaning (28 d of age) were distributed in 6 piglets/pen and 12 pens/treatment. In the prestarter phase (28 to 42 d of age), all pigs received the same commercial feed, including 3000 ppm ZnO. In the starter phase (42 to 63 d of age) (T1) included 3000 ppm of regular ZnO (2500 ppm Zn), and (T2) was supplemented with 110 ppm Zn from potentiated ZnO (HiZox). Average daily feed intake, ADG, G:F, and pig-MAP serum concentration, an acute phase protein commonly used as unspecific biomarker of disease or other acute phase reactions, were measured at 42 and 63 d of life. Pen of 6 piglets was the experimental unit and data were analyzed using the GLM procedure of SAS version 9.0. Piglets fed with T2-HiZox had improved ADG and G:F (P < 0.001) compared to piglets fed with T1-ZnO. In addition, at 63 d of age, the T2 group had a lower pig-MAP serum concentration than T1 group (1.71 vs. 0.95 µg/mL; P < 0.05) indicating higher health status in the T2 group. In conclusion, in low-medium sanitary conditions and in compliance with European regulation, HiZox significantly increased piglet growth compared to pharmacological dosage of regular ZnO in the starter phase. This can be explained by a better health of pigs expressed by a lower level of inflammatory protein pig-MAP.

Comparison of selenium levels and sources and dietary fat quality in diets for broiler breeders and layer hens.

Two experiments were carried out with broiler breeders (experiment 1) and laying hens (experiment 2) to study the effects of Se sources, in interaction with dietary level of Se or dietary fats on performance, Se incorporation into tissues (blood, liver, breast muscle, and egg) and eggs, hatchability, and glutathione peroxidase (GPX) activities in tissues and blood. Both experiments involved a 3 x 2 factorial arrangement of 3 Se sources (selenite, Se yeast, or B-Traxim Se) and either 2 levels of each source (0.1 or 0.3 mg/kg) or 2 fats (fresh or oxidized). Egg production was not affected by Se source or dietary fat in both experiments. Egg production was greater (P < 0.01) in breeder hens fed 0.3 mg/kg of Se in experiment 1. Hatchability of eggs from hens fed 0.1 mg/kg of Se was lower (P < 0.05) in hens fed Se yeast, whereas from hens fed 0.3 mg/kg of Se, it was comparable across treatments. Selenium in egg, liver, and breast muscle was greater (P < 0.01 or <0.05) in hens fed the greater concentration of Se. Eggs from breeder hens fed organic Se sources had greater (P < 0.01) Se content than those of inorganic source. Egg albumen from breeder fed Se yeast had the greatest Se (P < 0.01), whereas egg yolk from hens fed B-Traxim Se had the greatest Se (P < 0.05). These parameters were affected by interaction between dietary Se level and source (P < 0.01 or < 0.05). Selenium contents in liver and breast muscle were greater (P < 0.01) in hens fed Se yeast compared with hens fed other sources of Se. In experiment 1, liver GPX was greater (P < 0.01) in hens fed selenite or Se yeast, whereas plasma GPX was greater (P < 0.01) in hens fed selenite compared with B-Traxim Se or Se yeast. Supplementation with oxidized fat increased (P < 0.05) GPX in blood and liver. B-Traxim Se decreased (P < 0.05) malondialdehyde content in breast muscle of layers. It is concluded that broiler breeders require supplementation of 0.3 mg/kg of Se, and that there are numerous measurable advantages in using organic rather than inorganic sources for both breeders and layers.